Bio-Techne Corp. (TECH)
72.40
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
72.42
+0.02
(+0.02%)
After-Hours: 20:00
Bio-Techne Enterprise Value : 11.33B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 11.33B |
| October 01, 2026 | 11.33B |
| September 30, 2026 | 11.34B |
| September 29, 2026 | 11.32B |
| September 28, 2026 | 11.34B |
| September 25, 2026 | 11.36B |
| September 24, 2026 | 11.35B |
| September 23, 2026 | 11.34B |
| September 22, 2026 | 11.35B |
| September 21, 2026 | 11.34B |
| September 18, 2026 | 11.32B |
| September 17, 2026 | 11.33B |
| September 16, 2026 | 11.31B |
| September 15, 2026 | 11.32B |
| September 14, 2026 | 11.31B |
| September 11, 2026 | 11.28B |
| September 10, 2026 | 11.28B |
| September 09, 2026 | 11.30B |
| September 08, 2026 | 11.31B |
| September 04, 2026 | 11.33B |
| September 03, 2026 | 11.33B |
| September 02, 2026 | 11.31B |
| September 01, 2026 | 11.29B |
| August 31, 2026 | 11.31B |
| August 28, 2026 | 11.32B |
| Date | Value |
|---|---|
| August 27, 2026 | 11.34B |
| August 26, 2026 | 11.32B |
| August 25, 2026 | 11.31B |
| August 24, 2026 | 11.32B |
| August 21, 2026 | 11.31B |
| August 20, 2026 | 11.31B |
| August 19, 2026 | 11.34B |
| August 18, 2026 | 11.30B |
| August 17, 2026 | 11.32B |
| August 14, 2026 | 11.33B |
| August 13, 2026 | 11.29B |
| August 12, 2026 | 11.30B |
| August 11, 2026 | 11.29B |
| August 10, 2026 | 11.28B |
| August 07, 2026 | 11.31B |
| August 06, 2026 | 11.25B |
| August 05, 2026 | 11.26B |
| August 04, 2026 | 11.28B |
| August 03, 2026 | 11.29B |
| July 31, 2026 | 11.28B |
| July 30, 2026 | 11.27B |
| July 29, 2026 | 11.27B |
| July 28, 2026 | 11.27B |
| July 27, 2026 | 11.20B |
| July 24, 2026 | 11.20B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Repligen Corp. | 10.13B |
| BioLife Solutions, Inc. | 1.757B |
| MindWalk Holdings Corp. | 60.02M |
| Maravai Lifesciences Holdings, Inc. | 1.433B |
| MaxCyte, Inc. | 25.12M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 54.64M |
| Revenue (Quarterly) | 321.19M |
| Total Expenses (Quarterly) | 266.55M |
| EPS Diluted (Quarterly) | 0.348 |
| Gross Profit Margin (Quarterly) | 65.22% |
| Profit Margin (Quarterly) | 17.01% |
| Earnings Yield | 1.60% |
| Operating Earnings Yield | 2.40% |
| Normalized Earnings Yield | 1.762 |